Skip to Main Content

Author Details

Penny Flohr
The Institute of Cancer Research
1993
55
34
PMIDPaper TitleJournal TitlePublished Year
36725887Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.Oncogene2023
37844613Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.Nature2023
34066080Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients.Cancers (Basel)2021
34618582Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis.Science2021
34753775HER3 Is an Actionable Target in Advanced Prostate Cancer.Cancer Res2021
34103179Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA.Eur Urol2021
31806540Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.Lancet Oncol2020
31113841Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer.Clin Cancer Res2019
31036442Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer.Eur Urol2019
29741566Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts.Ann Oncol2018
30093450Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis.Clin Cancer Res2018
30006930Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap).Int J Cancer2018
30479699EpCAM<sup>high</sup> and EpCAM<sup>low</sup> circulating tumor cells in metastatic prostate and breast cancer patients.Oncotarget2018
30384500Scanning Electron Microscopy of Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles.Cancers (Basel)2018
29500065Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA).Eur Urol2018
29494651A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.PLoS One2018
29721202Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients.Oncotarget2018
27539393Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer.BJU Int2017
28383660CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair.Ann Oncol2017
28450425Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition.Cancer Discov2017
28068321Analysis of DNA methylation in single circulating tumor cells.Oncogene2017
27246360Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses.Clin Genitourin Cancer2016
27798103Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.Hum Mol Genet2016
27289566Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer.Eur Urol2016
25719830Androgen receptor expression in circulating tumour cells from castration-resistant prostate cancer patients treated with novel endocrine agents.Br J Cancer2015
28843286Integrative Clinical Genomics of Advanced Prostate Cancer.Cell2015
26510020DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.N Engl J Med2015
26379078PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients.Br J Cancer2015
26537258Plasma AR and abiraterone-resistant prostate cancer.Sci Transl Med2015
26000489Integrative clinical genomics of advanced prostate cancer.Cell2015
25232177Tumor clone dynamics in lethal prostate cancer.Sci Transl Med2014
21081515High-density tissue microarrays from prostate needle biopsies.J Clin Pathol2011
20104229Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer.Br J Cancer2010
20177423The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer.Prostate Cancer Prostatic Dis2010
19040532Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer.BJU Int2009
19638540An improved method for constructing tissue microarrays from prostate needle biopsy specimens.J Clin Pathol2009
19066166Hormone-sensitive prostate cancer: a case of ETS gene fusion heterogeneity.J Clin Pathol2009
17637754Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer.Oncogene2008
18594527Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer.Br J Cancer2008
17922029Complex patterns of ETS gene alteration arise during cancer development in the human prostate.Oncogene2008
17043636Diversity of TMPRSS2-ERG fusion transcripts in the human prostate.Oncogene2007
15583692Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer.Br J Cancer2005
14716298Amplification and overexpression of E2F3 in human bladder cancer.Oncogene2004
15492233A gene expression signature associated with metastatic outcome in human leiomyosarcomas.Cancer Res2004
12592363Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling.Br J Cancer2003
12606952Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays.Oncogene2003
11921288Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones.Genes Chromosomes Cancer2002
9265341[ESWL centers and determination of urinary calculus etiology. Results of a survey of 150 ESWL centers].Urologe A1997
8646236The ileal neobladder--updated experience with 306 patients.World J Urol1996
8928356[Ileal neobladder with anastomosis to the female urethra].Urologe A1996
  • 1 - 50 of 55

Recommended Authors

Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 30
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 18
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 6
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 25
Ashley E Ross
Northwestern University
Career Start Year 2003
Number of shared co-authors 27
Antonio Hurtado-Coll
University of British Columbia
Career Start Year 2002
Number of shared co-authors 17
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 24
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 9
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 21
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 21
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 14
J??rn Kamradt
Clinic of Urology and Pediatric Urology, University of Saarland
Career Start Year 1996
Number of shared co-authors 0
Feliksas Jankevicius
Clinic of Gastroenterology, Vilnius University
Career Start Year 1995
Number of shared co-authors 1
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 7
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 33
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 9
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 6
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 12
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 0
Christopher P Evans
University of California Davis
Career Start Year 1988
Number of shared co-authors 33
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 0
Freddie C Hamdy
University of Oxford
Career Start Year 1987
Number of shared co-authors 37
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 6
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 23
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 39
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1982
Number of shared co-authors 30
David E Neal
University of Oxford, John Radcliffe Hospital
Career Start Year 1981
Number of shared co-authors 37
Yves Fradet
CHU de Quebec-Universite Laval
Career Start Year 1975
Number of shared co-authors 17
Robert L Vessella
University of Washington
Career Start Year 1974
Number of shared co-authors 30
Theodorus H van der Kwast
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 22

Collaborators

Johann S de Bono
The Institute for Cancer Research
Co-authored papers 37
Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers 17
Gerhardt Attard
The Institute of Cancer Research
Co-authored papers 16
Susana Miranda
The Institute of Cancer Research
Co-authored papers 14
Jeremy Clark
Norwich Medical School, University of East Anglia
Co-authored papers 14
Sandra Edwards
The Institute of Cancer Research
Co-authored papers 12
Nina Tunariu
The Institute of Cancer Research
Co-authored papers 12
Joaquin Mateo
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Co-authored papers 12
Suzanne Carreira
The Institute of Cancer Research
Co-authored papers 11
Wei Yuan
The Institute for Cancer Research
Co-authored papers 11
Zafeiris Zafeiriou
Theageneion Anticancer Hospital
Co-authored papers 10
Roberta Ferraldeschi
Astex Pharmaceuticals
Co-authored papers 10
Adam Sharp
The Institute for Cancer Research
Co-authored papers 8
Christopher S Foster
The Institute of Cancer Research
Co-authored papers 8
Maryou B Lambros
The Institute of Cancer Research
Co-authored papers 7
Gunther Boysen
Co-authored papers 7
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 5
Cyril Fisher
University Hospitals Birmingham NHS Foundation Trust
Co-authored papers 5
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Raquel Perez-Lopez
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
Co-authored papers 5
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 5
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 4
Howard I Scher
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 4
Francesca Demichelis
University of Trento
Co-authored papers 4
Mark A Rubin
University of Bern
Co-authored papers 4
Niven Mehra
Radboud university medical center
Co-authored papers 4
Nening Dennis
Institute of Cancer Research
Co-authored papers 3
Matthew Clarke
Co-authored papers 3
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 3
Release 1.2